China CAS:50-27-1 Manufacturer

We insist over the principle of enhancement of 'High high quality, Efficiency, Sincerity and Down-to-earth working approach' to offer you with superb assistance of processing for CAS:50-27-1, We have exported to more than 40 countries and regions, which have gained fantastic popularity from our costumers everywhere in the globe.
CAS:50-27-1, With the superior and exceptional service, we've been well developed along with our customers. Expertise and know-how ensure that we are always enjoying the trust from our customers in our business activities. "Quality", "honesty" and "service" is our principle. Our loyalty and commitments remain respectfully at your service. Contact Us Today For further information, contact us now.

Hot Products

  • Tibolone

    Tibolone

    Tibolone complies with EP specification. DMF is approved.

    CAS:5630-53-5

  • Fluticasone Propionate

    Fluticasone Propionate

    Fluticasone propionate has CP, EP and USP specifications. DMF available.

    CAS:80474-14-2

  • Eslicarbazepine Acetate

    Eslicarbazepine Acetate

    Eslicarbazepine Acetate has In-house specification. DMF approved.

    CAS:236395-14-5

  • 17a-Hydroxyprogesterone

    17a-Hydroxyprogesterone

    17a-Hydroxyprogesterone is an endogenous progesteroid hormone similar to progesterone.

    CAS:68-96-2

  • Cyproterone Acetate Tablets

    Cyproterone Acetate Tablets

    Cyproterone Acetate Tablets Specifications:50mg*24
    Indications:Anti-androgen
  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept